Global Prostate Cancer Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 07-Nov-2022
No. of pages: 101
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Prostate Cancer companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Prostate Cancer market. Further, it explains the major drivers and regional dynamics of the global Prostate Cancer market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Astellas, Inc.

- AstraZeneca plc

- Johnson & Johnson

- Sanofi S.A

- Bristol Myers Squibb (BMS)

- Bayer AG

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Prostate Cancer Segment by Type

- Chemotherapy

- Hormonal Therapy

- Targeted Therapy

- Immunotherapy

Prostate Cancer Segment by Application

- Age Below 55

- Age 55-75

- Age Above 75

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Prostate Cancer market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Prostate Cancer market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Prostate Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate Cancer revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Prostate Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Prostate Cancer revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Astellas, Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bristol Myers Squibb (BMS) and Bayer AG, etc.

Global Prostate Cancer Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Hormonal Therapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Prostate Cancer Market Size (2017-2028)
2.2 Prostate Cancer Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Prostate Cancer Market Size by Region (2017-2022)
2.4 Global Prostate Cancer Market Size Forecast by Region (2023-2028)
2.5 Global Top Prostate Cancer Countries Ranking by Market Size
3 Prostate Cancer Competitive by Company
3.1 Global Prostate Cancer Revenue by Players
3.1.1 Global Prostate Cancer Revenue by Players (2017-2022)
3.1.2 Global Prostate Cancer Market Share by Players (2017-2022)
3.2 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Prostate Cancer Revenue
3.4 Global Prostate Cancer Market Concentration Ratio
3.4.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2021
3.5 Global Prostate Cancer Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Product Solution and Service
3.7 Date of Enter into Prostate Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Prostate Cancer Breakdown Data by Type
4.1 Global Prostate Cancer Historic Revenue by Type (2017-2022)
4.2 Global Prostate Cancer Forecasted Revenue by Type (2023-2028)
5 Global Prostate Cancer Breakdown Data by Application
5.1 Global Prostate Cancer Historic Market Size by Application (2017-2022)
5.2 Global Prostate Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Cancer Revenue by Company (2020-2022)
6.2 North America Prostate Cancer Revenue by Type (2017-2028)
6.3 North America Prostate Cancer Revenue by Application (2017-2028)
6.4 North America Prostate Cancer Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Prostate Cancer Revenue by Company (2020-2022)
7.2 Europe Prostate Cancer Revenue by Type (2017-2028)
7.3 Europe Prostate Cancer Revenue by Application (2017-2028)
7.4 Europe Prostate Cancer Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Revenue by Company (2020-2022)
8.2 Asia Pacific Prostate Cancer Revenue by Type (2017-2028)
8.3 Asia Pacific Prostate Cancer Revenue by Application (2017-2028)
8.4 Asia Pacific Prostate Cancer Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Prostate Cancer Revenue by Company (2020-2022)
9.2 Latin America Prostate Cancer Revenue by Type (2017-2028)
9.3 Latin America Prostate Cancer Revenue by Application (2017-2028)
9.4 Latin America Prostate Cancer Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostate Cancer Revenue by Company (2020-2022)
10.2 Middle East and Africa Prostate Cancer Revenue by Type (2017-2028)
10.3 Middle East and Africa Prostate Cancer Revenue by Application (2017-2028)
10.4 Middle East and Africa Prostate Cancer Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Astellas, Inc.
11.1.1 Astellas, Inc. Company Details
11.1.2 Astellas, Inc. Business Overview
11.1.3 Astellas, Inc. Prostate Cancer Products and Services
11.1.4 Astellas, Inc. Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.1.5 Astellas, Inc. Prostate Cancer SWOT Analysis
11.1.6 Astellas, Inc. Recent Developments
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Prostate Cancer Products and Services
11.2.4 AstraZeneca plc Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.2.5 AstraZeneca plc Prostate Cancer SWOT Analysis
11.2.6 AstraZeneca plc Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prostate Cancer Products and Services
11.3.4 Johnson & Johnson Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.3.5 Johnson & Johnson Prostate Cancer SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Details
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Prostate Cancer Products and Services
11.4.4 Sanofi S.A Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.4.5 Sanofi S.A Prostate Cancer SWOT Analysis
11.4.6 Sanofi S.A Recent Developments
11.5 Bristol Myers Squibb (BMS)
11.5.1 Bristol Myers Squibb (BMS) Company Details
11.5.2 Bristol Myers Squibb (BMS) Business Overview
11.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Products and Services
11.5.4 Bristol Myers Squibb (BMS) Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.5.5 Bristol Myers Squibb (BMS) Prostate Cancer SWOT Analysis
11.5.6 Bristol Myers Squibb (BMS) Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Prostate Cancer Products and Services
11.6.4 Bayer AG Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.6.5 Bayer AG Prostate Cancer SWOT Analysis
11.6.6 Bayer AG Recent Developments
12 Prostate Cancer Market Dynamics
12.1 Prostate Cancer Market Trends
12.2 Prostate Cancer Market Drivers
12.3 Prostate Cancer Market Challenges
12.4 Prostate Cancer Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Prostate Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormonal Therapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Immunotherapy
Table 6. Global Prostate Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Prostate Cancer Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Prostate Cancer Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Prostate Cancer Revenue Market Share by Region (2017-2022)
Table 10. Global Prostate Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Prostate Cancer Market Share by Players (2017-2022)
Table 12. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer as of 2021)
Table 13. Ranking of Global Top Prostate Cancer Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Prostate Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Prostate Cancer Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Prostate Cancer Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Prostate Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Prostate Cancer Revenue Market Share by Type (2017-2022)
Table 21. Global Prostate Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Prostate Cancer Revenue Market Share by Type (2023-2028)
Table 23. Global Prostate Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Prostate Cancer Revenue Market Share by Application (2017-2022)
Table 25. Global Prostate Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Prostate Cancer Revenue Market Share by Application (2023-2028)
Table 27. North America Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Prostate Cancer Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Prostate Cancer Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 62. Astellas, Inc. Company Details
Table 63. Astellas, Inc. Business Overview
Table 64. Astellas, Inc. Prostate Cancer Product and Services
Table 65. Astellas, Inc. Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 66. Astellas, Inc. Prostate Cancer SWOT Analysis
Table 67. Astellas, Inc. Recent Developments
Table 68. AstraZeneca plc Company Details
Table 69. AstraZeneca plc Business Overview
Table 70. AstraZeneca plc Prostate Cancer Product and Services
Table 71. AstraZeneca plc Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 72. AstraZeneca plc Prostate Cancer SWOT Analysis
Table 73. AstraZeneca plc Recent Developments
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Prostate Cancer Product and Services
Table 77. Johnson & Johnson Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 78. Johnson & Johnson Prostate Cancer SWOT Analysis
Table 79. Johnson & Johnson Recent Developments
Table 80. Sanofi S.A Company Details
Table 81. Sanofi S.A Business Overview
Table 82. Sanofi S.A Prostate Cancer Product and Services
Table 83. Sanofi S.A Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 84. Sanofi S.A Prostate Cancer SWOT Analysis
Table 85. Sanofi S.A Recent Developments
Table 86. Bristol Myers Squibb (BMS) Company Details
Table 87. Bristol Myers Squibb (BMS) Business Overview
Table 88. Bristol Myers Squibb (BMS) Prostate Cancer Product and Services
Table 89. Bristol Myers Squibb (BMS) Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 90. Bristol Myers Squibb (BMS) Prostate Cancer SWOT Analysis
Table 91. Bristol Myers Squibb (BMS) Recent Developments
Table 92. Bayer AG Company Details
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Prostate Cancer Product and Services
Table 95. Bayer AG Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 96. Bayer AG Prostate Cancer SWOT Analysis
Table 97. Bayer AG Recent Developments
Table 98. Prostate Cancer Market Trends
Table 99. Prostate Cancer Market Drivers
Table 100. Prostate Cancer Market Challenges
Table 101. Prostate Cancer Market Restraints
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Sales Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Features
Figure 3. Hormonal Therapy Features
Figure 4. Targeted Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Global Prostate Cancer Sales Market Share by Application: 2021 VS 2028
Figure 7. Age Below 55 Case Studies
Figure 8. Age 55-75 Case Studies
Figure 9. Age Above 75 Case Studies
Figure 10. Prostate Cancer Report Years Considered
Figure 11. Global Prostate Cancer Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Prostate Cancer Market Size 2017-2028 (US$ Million)
Figure 13. Global Prostate Cancer Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Prostate Cancer Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Prostate Cancer Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Prostate Cancer Market Share by Players in 2021
Figure 17. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Revenue in 2021
Figure 19. North America Prostate Cancer Revenue Market Share by Company in 2021
Figure 20. North America Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 21. North America Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 22. North America Prostate Cancer Revenue Share by Country (2017-2028)
Figure 23. U.S. Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Prostate Cancer Revenue Market Share by Company in 2021
Figure 26. Europe Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 27. Europe Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 28. Europe Prostate Cancer Revenue Share by Country (2017-2028)
Figure 29. Germany Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 30. France Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Prostate Cancer Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Prostate Cancer Revenue Share by Region (2017-2028)
Figure 38. China Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 41. India Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America Prostate Cancer Revenue Market Share by Company in 2021
Figure 50. Latin America Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 51. Latin America Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 52. Latin America Prostate Cancer Revenue Share by Country (2017-2028)
Figure 53. Mexico Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Prostate Cancer Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Prostate Cancer Revenue Share by Country (2017-2028)
Figure 60. Turkey Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 62. U.A.E Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 63. Astellas, Inc. Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 64. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 65. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 66. Sanofi S.A Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 67. Bristol Myers Squibb (BMS) Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 68. Bayer AG Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs